Activation of non-classical NMDA receptors by glycine impairs barrier function of brain endothelial cells
Lisa Epping,Christina B Schroeter,Christopher Nelke,Stefanie Bock,Lukas Gola,Nadine Ritter,Alexander M Herrmann,Saskia Räuber,Antonia Henes,Beatrice Wasser,Juncal Fernandez-Orth,Winfried Neuhaus,Stefan Bittner,Thomas Budde,Michael Platten,Stjepana Kovac,Guiscard Seebohm,Tobias Ruck,Manuela Cerina,Sven G Meuth
DOI: https://doi.org/10.1007/s00018-022-04502-z
2022-08-11
Abstract:Blood-brain barrier (BBB) integrity is necessary to maintain homeostasis of the central nervous system (CNS). NMDA receptor (NMDAR) function and expression have been implicated in BBB integrity. However, as evidenced in neuroinflammatory conditions, BBB disruption contributes to immune cell infiltration and propagation of inflammatory pathways. Currently, our understanding of the pathophysiological role of NMDAR signaling on endothelial cells remains incomplete. Thus, we investigated NMDAR function on primary mouse brain microvascular endothelial cells (MBMECs). We detected glycine-responsive NMDAR channels, composed of functional GluN1, GluN2A and GluN3A subunits. Importantly, application of glycine alone, but not glutamate, was sufficient to induce NMDAR-mediated currents and an increase in intracellular Ca2+ concentrations. Functionally, glycine-mediated NMDAR activation leads to loss of BBB integrity and changes in actin distribution. Treatment of oocytes that express NMDARs composed of different subunits, with GluN1 and GluN3A binding site inhibitors, resulted in abrogation of NMDAR signaling as measured by two-electrode voltage clamp (TEVC). This effect was only detected in the presence of the GluN2A subunits, suggesting the latter as prerequisite for pharmacological modulation of NMDARs on brain endothelial cells. Taken together, our findings argue for a novel role of glycine as NMDAR ligand on endothelial cells shaping BBB integrity.